Rui Han, Hongxing Yang, Lingeng Lu, Lizhu Lin. "Retraction Note: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis." Scientific Reports, 2025. doi:10.1038/s41598-025-11770-9